Visualizing drug treatment pathways in type 2 diabetes

被引:0
|
作者
Patrick, Amanda R. [1 ]
Nemeth, Sheila [1 ]
Adimadhyam, Sruthi [1 ]
机构
[1] Aetion Inc, Boston, MA USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1063
引用
收藏
页码:514 / 514
页数:1
相关论文
共 50 条
  • [41] Drug evaluation: Rivoglitazone, a new oral therapy for the treatment of type 2 diabetes
    Schimke, Katrin
    Davis, Timothy M. E.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (04) : 338 - 344
  • [42] Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes
    Stenlof, K.
    Rossner, S.
    Vercruysse, F.
    Kumar, A.
    Fitchet, M.
    Sjostrom, L.
    DIABETES OBESITY & METABOLISM, 2007, 9 (03): : 360 - 368
  • [44] Imeglimin: a new antidiabetic drug with potential for the treatment of patients with type 2 diabetes
    Nowak, Mariusz
    Grzeszczak, Wladyslaw
    ENDOKRYNOLOGIA POLSKA, 2022, 73 (02) : 361 - 370
  • [45] DRUG-TREATMENT OF OBESITY IN TYPE-2 DIABETES-MELLITUS
    CARPENTER, MA
    BODANSKY, HJ
    DIABETIC MEDICINE, 1990, 7 (02) : 99 - 104
  • [46] Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes
    Rizos, Christos V.
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (01) : 117 - 125
  • [47] Stevioside as a potential useful drug in the treatment of type 2 diabetes and the metabolic syndrome
    Jeppesen, Per B.
    JOURNAL OF FOOD AGRICULTURE & ENVIRONMENT, 2004, 2 (3-4): : 292 - 295
  • [48] Drug Therapy of the Type-2 Diabetes Metformin remains the Treatment of Choice
    Pavlicek, V.
    DIABETOLOGE, 2016, 12 (05): : 362 - 363
  • [49] Treatment of type 2 diabetes
    Landgraf, Ruediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald H.
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Wiesner, Tobias
    Siegel, Erhard
    DIABETOLOGIE, 2024, : 212 - 260
  • [50] Treatment of type 2 diabetes
    Scheen, AJ
    ACTA CLINICA BELGICA, 2003, 58 (05) : 318 - 324